Bowe A, Poonawalla I, Tindal M, Meah Y, Schwab P. Cardiovascular outcomes with Dulaglutide vs. Liraglutide. Poster presented at the 80th American Diabetes Association Scientific Sessions; June 13, 2020.
Sheer R, Schwab P, Essex MN, Cappelleri JC, Reiners A, Bobula J, Pasquale MK. Factors related to the use of topical vs. oral NSAIDs for sprains, strains, and contusions in a senior population: a retrospective analysis of administrative claims data. Drugs Aging. 2018 Oct;35(10):937-50. doi: 10.1007/s40266-018-0585-8
Douglas AG, Schwab P, Lane D, Kennedy K, Slabaugh SL, Bowe A. A comparison of brand and biosimilar granulocyte-colony stimulating factors for prophylaxis of chemotherapy-induced febrile neutropenia. J Manag Care Spec Pharm. 2017 Dec;23(12):1221-6. doi: 10.18553/jmcp.2017.23.12.1221
Yu S, Schwab P, Bian B, Radican L, Tunceli K. Use of add-on treatment to Metformin monotherapy for patients with type 2 Diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016 Mar;22(3):272-80. doi: 10.18553/jmcp.2016.22.3.272
Schwab P, Louder A, Li Y, Mallick R, Bays H. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6